SOX2 and cancer: Moreover, the CMCAFs treatment induced the expression of EMT and cancer stemness markers in NOZ and GBC-SD cells, as revealed by reduced E-cadherin expression and increased vimentin, Sox2, CD44, Nanog and Oct4 expression (Fig. 2c and Additional file 4: Fig. S1F).